New Funding Awards March 2023

Sponsored Research

Gary Felker of Cardiology has received a sub-award (1OT2HL156812-01) through the Research Triangle Institute International for a project entitled "RECOVER Exercise Intolerance Protocol." Total funding will be $15,813,546.

William Jones of Cardiology has received a sub-award (HA-2021C3-24767) through the Yale University for a project entitled "A TriaL ComparIng the EffectiVEness and ToleraBility of MEdicaTions in Older Adults with STablE Angina and Multiple ChRonic Conditions: The LIVE BETTER Trial." Total funding will be $25,092.

Sreekanth Vemulapalli of Cardiology has received a sub-award through the Vascular Cures for a project entitled "Eugene Washington PCORI Engagement Award." Total funding will be $22,307.

Omobonike Sanders of Gastroenterology has received a sub-award through the Regents of the University of Michigan for a project entitled "Sub-Award Repository Samples -Noninvasive Assessment of Esophageal Varices in Patients with Unresectable Hepatocellular Carcinoma - Genentech." Total funding will be $10,500.

Maria Marquine of Geriatrics has received an award (K24-AG075240-02) from the National Institutes of Health for a project entitled "Research and Mentoring on Neurocognitive Disparities in Aging." Total funding will be $738,622.

Maria Marquine of Geriatrics has received a sub-award through the University of California - San Diego for a project entitled "Disparities in Neurocognitive Impairment among Hispanics/Latinos in the US with Parkinson's Disease: The Role of Cardiovascular Risk." Total funding will be $12,504.

Erin Gettler of Infectious Diseases has received a sub-award (5U54-CK000607-02-00) through the Rush University Medical Center for a project entitled "Chlorhexidine Effectiveness Assessment in Non-Intensive Care Unit Hematology-Oncology/Bone Marrow Transplantation Units (CLEAN-HEME)." Total funding will be $23,129.

Tomokazu Souma of Nephrology has received an award (1R01-DK133369-01A1) from the National Institutes of Health for a project entitled "Ferroptosis and Ferroptotic Stress in Maladaptive Renal Repair - R01." Total funding will be $2,504,742.

Timothy McMahon of Pulmonary has received an award (1R01-HL161071-01A1) from the National Institutes of Health for a project entitled "Red blood cell ATP export and transfusion in sepsis (R01)." Total funding will be $2,762,680.

Neelima Navuluri of Pulmonary has received an award from the Parker B. Francis Foundation for a project entitled "Post-Tuberculosis Lung Disease: Clinical Phenotypes and Barriers to Treatment." Total funding will be $225,000.

Industry Sponsored Clinical Trials

Adrian Hernandez of Cardiology has received an award from Pfizer, Inc. for a project entitled "Health and Wellness Information Project." Total funding will be $529,708.

Adrian Hernandez of Cardiology has received an award from Novo Nordisk, Inc. for a project entitled "CardioHealth Alliance Membership." Total funding will be $91,667.

Zak Loring of Cardiology has received a sub-award (R43-HL158282-01) through Huxley Medical, Inc. for a project entitled "Non-invasive hemodynamic sensor patch for remote, early detection and prevention of heart failure with left bundle branch block." Total funding will be $81,724.

Kishan Parikh of Cardiology has received an award from Alleviant Medical, Inc. for a project entitled "ALLAY-HF." Total funding will be $1,046,263.

Cristiana Costa Chase of Cell Therapy has received an award from GlaxoSmithKline for a project entitled "A Collaborative Community Effort using belantamab mafodotin in Relapsed/Refractory Myeloma." Total funding will be $548,550.

Carlos Decastro of Cell Therapy has received an award from BioCryst Pharmaceuticals, Inc. for a project entitled "BioCryst: BCX9930 Mono for PNH in subjects with Inadequate Response to C5 Inhibitor Therapy." Total funding will be $15,960.

Ahmed Galal of Cell Therapy has received an award from Precision BioSciences , Inc. for a project entitled "PBCAR0191-01." Total funding will be $312,018.

Thomas Leblanc of Cell Therapy has received an award from AbbVie Inc. for a project entitled "A center-based chart review study to assess treatment outcomes of venetoclax for the treatment of acute myeloid leukemia." Total funding will be $70,337.

Matthew McKinney of Cell Therapy has received an award from Cellectar Biosciences, Inc. for a project entitled "An Open-Label, Multicenter, Phase 2 Study of CLR 131 in Patients with Relapsed or Refractory (R/R) Select B-Cell Malignancies (CLOVER-1) and Expansion Cohort in Patients with Waldenstrom Macroglobulinemia (CLOVER-WaM)." Total funding will be $759,240.

Andrew Muir of Gastroenterology has received an award from Dicerna Pharmaceuticals, Inc. for a project entitled "A Phase 2, Randomized, Double-blind, Placebo-controlled Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Dose Levels of Belcesiran in Patients with Alpha-1 Antitrypsin Deficiency-Associated Liver Disease." Total funding will be $242,013.

Yuval Patel of Gastroenterology has received an award from Salix Pharmaceuticals for a project entitled "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE SOLID DISPERSION (SSD) TABLETS FOR THE DELAY OF ENCEPHALOPATHY DECOMPENSATION IN CIRRHOSIS (RED-C)." Total funding will be $220,316.

Thuy Le of Infectious Diseases has received a sub-award (75N93022C00027) through IMMY for a project entitled "Development of a point of care lateral flow antigen test for talaromycosis." Total funding will be $682,813.

Scott Antonia of Oncology has received an award from Regeneron Pharmaceuticals, Inc. for a project entitled "A phase II study of PCSK9 inhibitor Alirocumab and PD-1 inhibitor Cemiplimab in patients with metastatic, PD-1 refractory non-small cell lung cancer (NSCLC)." Total funding will be $986,853.

Michael Harrison of Oncology has received an award from Bristol-Myers Squibb Company for a project entitled "BMS 022-009: Immunotherapy + Docetaxel for chemo-naive mCRPC patients." Total funding will be $21,749.

Christopher Hoimes of Oncology has received an award from Tyra Biosciences, Inc. for a project entitled "Tyra-Surf-301." Total funding will be $357,762.

Jason Somarelli of Oncology has received an award from Dolphin Quest for a project entitled "An integrated physiology and genomics analysis to define molecular adaptations to diving." Total funding will be $9,944.

Thomas Stinchcombe of Oncology has received an award from Nuvalent, Inc. for a project entitled "Phase 1/2 Study of the Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor NVL-655." Total funding will be $792,365.

Kamran Mahmood of Pulmonary has received an award from Cook Research for a project entitled "Cook Pleural Drainage Sets Post-Market Study Plan. Global Clinical Number: MDR-1908." Total funding will be $105,801.

Lake Morrison of Pulmonary has received an award from Boehringer Ingelheim Pharmaceuticals, Inc. for a project entitled "A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Idiopathic Pulmonary Fibrosis (IPF)." Total funding will be $246,813.

Lake Morrison of Pulmonary has received an award from Boehringer Ingelheim Pharmaceuticals, Inc. for a project entitled "A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks inpatients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)." Total funding will be $246,813.

Lake Morrison of Pulmonary has received an award from Daewoong Pharmaceutical Co., Ltd for a project entitled "Daewoong A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DWN12088 in Patients With Idiopathic Pulmonary Fibrosis." Total funding will be $160,899.

Ankoor Shah of Rheumatology has received an award from Talaris Therapeutics for a project entitled "A single-arm, multi-center, open-label proof of concept safety and efficacy study of FCR001 cell-based therapy in adults with rapidly progressive diffuse cutaneous systemic sclerosis at risk for organ failure." Total funding will be $761,172.

 

Share